Eliza Argonza‐Aviles

Final 5‐year results of Z‐FAST trial

Adam Brufsky, W G Harker, J. Thaddeus Beck et al. · Cancer · 2011 · 189 citations

The Effect of Zoledronic Acid on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The Z-FAST Study 5-Year Final Follow-Up.

Adam Brufsky, Graydon Harker, J. Thaddeus Beck et al. · Cancer Research · 2009 · 59 citations

Breast Oncology, Pharmacotherapy, Osteoporosis +18

Bone Marker–Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study

Noopur Raje, Robert Vescio, Charles W. Montgomery et al. · Clinical Cancer Research · 2015 · 49 citations

Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer

Kishan J. Pandya, Ajeet Gajra, Ghulam Warsi et al. · Lung Cancer · 2009 · 32 citations

Zoledronic Acid, Unresectable Stage Iiib, Oncology +6

Results of a Multicenter Open-Label Randomized Trial Evaluating Infusion Duration of Zoledronic Acid in Multiple Myeloma Patients (the ZMAX Trial)

James R. Berenson, Ralph V. Boccia, Timothy Lopez et al. · The Journal of Supportive Oncology · 2011 · 10 citations